This inventor holds 3 USPTO granted patents, plus 1 CIPO patent and 2 EPO patents. Top assignees: The University of Nantes, Iason Gmbh, National Institute of Health and Medical Research. Active years: 2015-2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 156 
1 out of 1 
1 out of 1,853 
Years Active: 2015-2017
Title: Jacques Barbet: Innovator in Cancer Treatment
Introduction
Jacques Barbet is a notable inventor based in Nantes, France. He has made significant contributions to the field of cancer treatment through his innovative patents. With a total of 3 patents, Barbet's work focuses on developing targeted therapies for various types of tumors.
Latest Patents
One of Barbet's latest patents is titled "Neurotensin analogues for radioisotope targeting to neurotensin receptor-positive tumors." This invention relates to a new neurotensin analogue, or a salt thereof, that is useful for targeting neurotensin receptor-positive tumors, including ductal pancreatic adenocarcinoma, exocrine pancreatic cancer, invasive ductal breast cancers, colon adenocarcinoma, small cell lung carcinoma, Ewing sarcoma, meningioma, medulloblastoma, and astrocytoma. Another significant patent is the "Use of monoclonal antibodies specific to the O-acetylated form of GD2 ganglioside for the treatment of certain cancers." This patent describes monoclonal antibodies that recognize only the O-acetylated form of the GD2 ganglioside, which can be used for the diagnosis and treatment of cancers expressing this specific form, thereby increasing diagnostic specificity and reducing treatment toxicity.
Career Highlights
Throughout his career, Jacques Barbet has worked with esteemed institutions such as Université de Nantes and the Institut National de la Santé et de la Recherche Médicale. His research has focused on advancing cancer therapies, particularly through the development of targeted treatments.
Collaborations
Barbet has collaborated with notable colleagues, including Jean-Marie Mussini and Jacques Aubry. These partnerships have contributed to the advancement of his research and the successful development of his patents.
Conclusion
Jacques Barbet's innovative work in cancer treatment exemplifies the impact of targeted therapies in modern medicine. His contributions continue to pave the way for advancements in the diagnosis and treatment of various cancers.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile